These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 4144465)

  • 1. Specific depletion of GVH reactivity of mouse lymphocytes by adsorption on allogeneic fibroblast monolayers.
    Lonai P; Eliraz A; Wekerle H; Feldman M
    Transplant Proc; 1973 Mar; 5(1):857-9. PubMed ID: 4144465
    [No Abstract]   [Full Text] [Related]  

  • 2. Graft-vs-host reactivity of mouse thymocytes: effect of cortisone pretreatment of donors.
    Tigelaar RE; Asofsky R
    J Immunol; 1973 Feb; 110(2):567-74. PubMed ID: 4405321
    [No Abstract]   [Full Text] [Related]  

  • 3. Syngeneic GvH induced in popliteal lymph nodes by spleen cells of old C57BL/6 mice.
    Gozes Y; Umiel T; Meshorer A; Trainin N
    J Immunol; 1978 Dec; 121(6):2199-204. PubMed ID: 31401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific partial depletion of graft-vs-host activity by incubation and centrifugation of mouse spleen cells on allogeneic spleen cell monolayers.
    Mage MG; McHugh LL
    J Immunol; 1975 Oct; 115(4):911-3. PubMed ID: 240886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention of graft-vs-host activity in non-adherent spleen cells after depletion of cytotoxic activity by incubation on allogeneic target cells.
    Mage MG; McHugh LL
    J Immunol; 1973 Aug; 111(2):652-5. PubMed ID: 4146231
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inactivation of cytotoxic lymphocytes after adsorption on 51Cr-labeled fibroblast monolayers.
    Ritter J; Lohmann-Matthes ML; Fischer H
    Transplantation; 1973 Dec; 16(6):579-82. PubMed ID: 4148250
    [No Abstract]   [Full Text] [Related]  

  • 8. Thymus dependence of lymphocyte trapping.
    Zatz MM; Gershon RK
    J Immunol; 1974 Jan; 112(1):101-6. PubMed ID: 4149589
    [No Abstract]   [Full Text] [Related]  

  • 9. Absorption of normal lymphocytes on allogeneic spleen monolayers: depletion of alloreactivity is due to inhibition of CTL induction by released monolayer cells.
    Kelso A
    J Immunol; 1981 Oct; 127(4):1563-9. PubMed ID: 6456308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recruitment of effector lymphocytes by initiator lymphocytes. Recruited lymphocytes are immunospecific and include graft-versus-host-reactive lymphocytes.
    Livnat S; Cohen IR
    J Immunol; 1976 Aug; 117(2):614-9. PubMed ID: 59784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between proliferative and effector phases of the mixed lymphocyte reaction and graft-vs-host reaction.
    Howe M; Berman L; Cohen L
    J Immunol; 1973 Oct; 111(4):1243-9. PubMed ID: 4147022
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-CD4 IgG2a monoclonal antibody treatment prevents the expansion of T cells in the spleen during murine graft-vs-host disease.
    Noort WA; Benner R; Savelkoul HF
    Transplant Proc; 1995 Feb; 27(1):384-6. PubMed ID: 7879030
    [No Abstract]   [Full Text] [Related]  

  • 13. The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity.
    Rouse BT; Wagner H
    J Immunol; 1972 Dec; 109(6):1282-9. PubMed ID: 4404454
    [No Abstract]   [Full Text] [Related]  

  • 14. [Participation of phytohemagglutinin-transformed mouse lymphocytes in development of the "graft-versus-host" reaction].
    Nesterenko VG; Koval'chuk LV
    Biull Eksp Biol Med; 1976 Sep; 82(9):1096-8. PubMed ID: 11013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of the age of donors and recipients on the regional graft-versus-host reaction in mice.
    Skowron-Cendrzak A; Kubera M; Bubak-Satora M; Godowicz W
    Arch Immunol Ther Exp (Warsz); 1991; 39(3):185-91. PubMed ID: 1810211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific depletion of graft-versus-host activity of normal or allosensitized parental spleen cells.
    Rózalska B
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):417-21. PubMed ID: 6200087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute graft-versus-host reaction in mice. I. Cellular events.
    Vitale B; Jaksić B; Matosić M; Silobrcić V; Tomazić V
    Transplantation; 1976 Jun; 21(6):502-10. PubMed ID: 7034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node basophiles and mast cells in the local graft-versus-host reaction in mice.
    Włodarski KH; Skarpetowski A; Kowalski M; Włodarski PK
    Arch Immunol Ther Exp (Warsz); 1992; 40(5-6):297-300. PubMed ID: 1340185
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction and suppression of graft-versus-host reactivity in B6.C-H-2 mutant mice.
    Molendijk A; van Gurp RJ; van Oudenaren A; Benner R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2698-9. PubMed ID: 2978897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.